Pune, May 30, 2022 (GLOBE NEWSWIRE) -- The global HbA1c testing market size was worth USD 1.3 billion in 2021. The market valuation is projected to increase from USD 1.3 billion in 2021 to USD 3.17 billion by 2031 at a CAGR of 8.5% during 2021-2031 owing to the rising prevalence of diabetes that has led to the rising need for testing and monitoring glucose levels
Growth Engines
Diabetes has affected millions of people across the globe and the number of people with diabetes keeps on rising. According to the International Diabetes Federation, in 2019, worldwide, approximately 463 million adults aged 20-79 years were living with diabetes and the number is anticipated to rise to 700 million by 2045.
The increasing prevalence of diabetes worldwide has led to rising demand for tests. As the HbA1c test helps in determining the average level of blood sugar over the past 2 to 3 months, these tests are further combined with other diagnostic testing methods to derive efficient disease diagnosis and therefore help inappropriate decision-making on treatments. The global HbA1c testing market is witnessing considerable growth due to factors such as incessant growth in the prevalence of diabetes, increasing prescription rate from physicians, and low testing costs.
The global HbA1c testing market has been analyzed from four perspectives: Product, Technology, End User, and Region.
Download Exclusive Sample of Report @ https://growthplusreports.com/inquiry/request-sample/hba1c-testing-market/7692
Key Industry Development-
In May 2020, EKF Diagnostics signed a 3-year distribution agreement with Tosoh Europe N.V. for a Quo-Test HbA1c point-of-care (POC) analyzer in the Middle East and Africa. The quo-test analyzer is fully automated and quantifies HbA1c from a 4μL sample taken from a finger prick or venous whole blood.
Restraints Factors-
However, studies have shown that the presence of genetic variants of hemoglobin can affect the accuracy of HbA1c measurements. Iron deficiency anemia and vitamin B12 deficiency can lead to falsely elevated HbA1c results. Such factors are challenging the adoption of the global HbA1c testing market.
Excerpts from ‘By Technology Segmentation’
Based on technology, the market has been segmented into: -
- Ion-exchange HPLC
- Boronate Affinity Chromatography
- Turbidimetric Inhibition Immunoassay
- Direct Enzymatic Assay
- Other Technologies
Ion-exchange HPLC segment held the largest share in the HbA1c testing market.
Higher accuracy, sensitivity, and low cost for getting HbA1c results are some of the advantages of using ion-exchange HPLC for measuring HbA1c testing.
These advantages are driving the use of ion-exchange HPLC.
Excerpts from ‘By Region Segmentation’
Regionally, the global HbA1c testing market has been segmented into:-
- North America
- Europe
- Asia Pacific
- The Rest of the World (RoW).
North America held the largest share in the global HbA1c testing market.
Factors such as the rising geriatric population suffering from diabetes coupled with the growing need for continuous glucose level monitoring are boosting the HbA1c testing market growth. Moreover, factors such as the presence of prominent players with diverse product portfolios and the large number of laboratories providing HbA1c testing are also playing a pivotal role in propelling the growth of this market in the region.
Furthermore, an increase in awareness about the availability of novel tests and the growing adoption of hbA1c testing due to increasing prescriptions by physicians and endocrinologists contribute to the current dominance of the North American market. Additionally, favorable reimbursements and sufficient insurance coverage also support the dominance of North America in the global HbA1c testing market.
A significantly large patient pool is also a major attribute of the North American market.
There has been a consistent increase in the general prevalence of diabetes across all age groups in the region. This fact, coupled with increasing awareness regarding the implications of diabetes in the long run in the form of different comorbidities has led to the growing adoption of advanced diagnostic and monitoring techniques for diabetes management and thus the growth of HbA1c testing solutions.
Ask here for more customization study@ https://growthplusreports.com/inquiry/customization/hba1c-testing-market/7692
Excerpts from ‘Competitive Landscape’
The prominent players operating in the global HbA1c testing market include:-
- Abbott
- Siemens Healthcare Private Limited
- ARKRAY, Inc
- Bio-Rad Laboratories, Inc
- F. Hoffmann-La Roche Ltd
- PTS Diagnostics
- Transasia Bio-Medicals
- Danaher
- Trinity Biotech
- Tosoh Corporation and Among others
By Products Outlook:
- Instruments
- Consumables
By Technology Outlook:
- Ion-Exchange HPLC
- Boronate Affinity Chromatography
- Turbidimetric Inhibition Immunoassay
- Direct Enzymatic Assay
By End Users Outlook:
- Hospitals & Clinics
- Diagnostic Laboratories
- Home Care
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- 'Business Profile' of Key Players
Buy this Premium Research Report@ https://growthplusreports.com/checkout?_token=4WMbbwaVL1BHqF0VCS0RzYSSrXk4qyxUJRyislwX&report_id=7692&license=Single
Check out more healthcare-related studies published by Growth Plus Reports:
Defibrillators Market by Type (Implantable Cardioverter Defibrillator and External Defibrillator), End User (Hospitals & Clinics, Pre-hospitals, Public Access Market, Home Care Settings, and Alternate Care Market)–Global Outlook & Forecast 2021-2031
Autoimmune Disease Diagnosis Market by Product (Instruments and Consumables & Assay Kits), Type (Localized Autoimmune Disease Diagnostics, Systemic Autoimmune Disease Diagnostics), Test Type (Routine Laboratory Tests, Autoantibodies & Immunologic Test, and Inflammatory Markers)–Global Outlook& Forecast 2021-2031
Active Pharmaceutical Ingredient (API) Market by Type [Generic and Branded], Type Of Manufacturer [Merchant (Contract) Manufacturers and Captive (In-House) Manufacturers], Application [Cardiovascular Disease, Infectious Diseases, Oncology, Neurological Diseases, Diabetes, and Respiratory Diseases] – Global Outlook & Forecast 2021-2031
About Us:
Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
